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Background: Quality improvement initiatives in cardiac surgery largely rely on risk prediction models. Most often,
these models include isolated populations and describe isolated end-points. However, with the changing clinical
profile of the cardiac surgical patients, mixed populations models are required to accurately represent the majority
of the surgical population. Also, composite model end-points of morbidity and mortality, better reflect outcomes
experienced by patients.
Methods: The model development cohort included 4,270 patients who underwent aortic or mitral valve
replacement, or mitral valve repair with/without coronary artery bypass grafting, or isolated coronary artery bypass
grafting. A composite end-point of infection, stroke, acute renal failure, or death was evaluated. Age, sex, surgical
priority, and procedure were forced, a priori, into the model and then stepwise selection of candidate variables was
utilized. Model performance was evaluated by concordance statistic, Hosmer-Lemeshow Goodness of Fit, and
calibration plots. Bootstrap technique was employed to validate the model.
Results: The model included 16 variables. Several variables were significant such as, emergent surgical priority
(OR 4.3; 95% CI 2.9-7.4), CABG + Valve procedure (OR 2.3; 95% CI 1.8-3.0), and frailty (OR 1.7; 95% CI 1.2-2.5),
among others. The concordance statistic for the major adverse cardiac events model in a mixed population
was 0.764 (95% CL; 0.75-0.79) and had excellent calibration.
Conclusions: Development of predictive models with composite end-points and mixed procedure population
can yield robust statistical and clinical validity. As they more accurately reflect current cardiac surgical profile,
models such as this, are an essential tool in quality improvement efforts.
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Quality improvement initiatives (QI), a cornerstone of
cardiac surgery, have largely relied on predictive models
to advance the quality of care cardiac surgical patients
receive. For the last two decades, coronary artery bypass
grafting (CABG) has dominated clinical practice in car-
diac surgery, and therefore the majority of quality im-
provement initiatives have focused on surgical outcomes
following isolated CABG surgery [1-4]. More recently,
however, there has been an increase in valve and valve-* Correspondence: cherman@dal.ca
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reproduction in any medium, provided the orCABG cases in cardiac surgery [5] and existing predict-
ive models for isolated CABG may not accurately reflect
current practice profiles. These models may achieve
great statistical validity but lack clinical validity as the
models are applicable to only a decreasing percentage
of the clinical practice. In order to maintain continued
success in quality improvement, it is important to delin-
eate risk profiles for a group of mixed procedures, includ-
ing CABG, valve, and valve + CABG, that characterize
current clinical practice.
To accommodate the shift in the profile of cardiac
surgical practice, isolated valve and valve plus CABG
models have been developed [5-10]. Some debate exists
regarding the validity of developing models with hetero-l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Herman et al. Journal of Cardiothoracic Surgery 2013, 8:177 Page 2 of 6
http://www.cardiothoracicsurgery.org/content/8/1/177geneous procedures with some advocating for single
procedure models [7,9,10]. Homogeneity within the popu-
lation allows for simplicity of model development with
improved reliability but limits sample size available for
development and validation [5]. Although mixed proce-
dural models may be confounded or biased by different
pathophysiological and risk profiles, they improve sample
size [5] and increase their relevance to current surgical
practice.
Largely, mixed procedural models have focused on
aortic/mitral or valve +/− CABG, with few CABG, valve
and CABG +valve models present in the literature. The
EuroSCORE model, one of the mostly widely used cardiac
surgical prognostic models, has successfully achieved both
statistical and clinical relevance as it applies to a mixed
surgical practice including CABG, valve, and CABG +
valve. However its development and validation cohort
were derived from a population sample that is over fif-
teen years old [11] limiting its applicability to a contem-
porary surgical practice. Recently, the EuroSCORE II
updated its risk model obviating some of the limitations
of the original model [12]. However, the performance of
this heterogeneous procedure model performed poorly in
risk prediction for several of its component procedures
types [13,14]. In addition, both the EuroSCORE and the
EuroSCORE II are only a mortality model.
Many models describe death as a lone end point, des-
pite that fact that cardiac patients experience a variety of
relevant morbidity. These alternate surgical outcomes
are also important quality indicators for cardiac surgical
care [15] and targets for QI initiatives. Subsequently,
modeling composite end points such as, major adverse
cardiac events (MACE), that included both important
morbidity and mortality may provide more insight to
the surgical outcomes experienced by patients as well as
increase statistical power in low frequency end points.
Comprehensive models that include most major cardiac
surgical procedures may allow for better understanding
of patient risk profiles and facilitate quality improvement
initiatives directed towards the majority of patients seen in
current practice. The objective of this paper is to develop
a CABG, valve, CABG + valve morbidity and mortality
(MACE) model that can be applied to the majority of
patients undergoing cardiac surgery.
Methods
Data source and study population
This study is a retrospective cohort design. The Maritime
Heart Center Cardiac Surgery Registry is a detailed clinical
database housed at the Queen Elizabeth II Health Science
Center (QEII HSC) Halifax, Nova Scotia, an academic
tertiary care centre performing 1200 cardiac cases per
year. It includes pre-, intra-, and post-operative data pro-
spectively collected on all cardiac surgical cases performedat the QEII HSC from 1995 to present. Trained abstrac-
tors collect data, and a database administrator maintains
the registry. The database is audited annually.
The model development cohort included all patients
undergoing isolated coronary artery bypass grafting
(CABG), isolated aortic valve replacement, isolated mitral
valve repair or replacement with or without concomitant
CABG performed at the QEII HSC since 2004 to 2009.
The development cohort was restricted to these years in
order to maintain a modern population relevant to current
clinical practice.
The primary outcome was a composite end point de-
fined as Major Adverse Cardiac Events (MACE) that
included in-hospital death, stroke (persisting at discharge
or transient), acute renal failure (new post-operative renal
failure or acute on chronic (>50% increase from baseline




Candidate variables for model development included the
following preoperative characteristics: age, sex, diabetes,
frailty, chronic obstructive pulmonary disease, redo ster-
notomy, atrial fibrillation, hemoglobin, peripheral vascu-
lar disease, cerebro-vascular disease, creatinine, ejection
fraction < 40%, New York Heart Association classifica-
tion (NYHA I-IV) and body mass index (BMI). Surgery-
related data such as urgency of surgery, and procedure
type were also included. These candidate variables were
chosen a priori and selected through rigorous review of
the literature [1-9,16-18] (Table 1).
Multi-colinearity of candidate variables was assessed
with variance inflation factor (VIF) (Additional file 1: see
Statistical Methods). The linear relationships of the nat-
ural variables and their transformations were assessed
through locally weighted scatterplot smoothing (LOESS)
regression [19] (see Additional file 1: Linearity and Trans-
formations and Figure 2-3). The WHO classification of
BMI was used [20].
Model evaluation
A multivariate logistic regression analysis was used to
describe MACE.
Age, sex, procedure type and surgical priority were
chosen a priori and forced into the model. Stepwise selec-
tion was implemented for the remainder of the candidate
variables. The concordance statistic and −2 log likelihood
were evaluated to assess the contribution of each variable
to the model. If a variable did not contribute to an in-
crease in the C or −2 log likelihood statistic it was not
retained in the model.
Model discrimination was determined using the con-
cordance statistic [21]. Model calibration was assessed by
Table 1 Model variable definitions
Variable Definition
Age Patient age at the time of surgery
Gender Male or Female
Body mass index Calculated in kilograms and centimeters.
Diabetes Any history of Diabetes Mellitus, regardless of
duration
Pre-op Afib Any previously documented history of Atrial
Fibrillation
COPD Any preivous documented history of Chronic
Obstructive Pulmonary Disease
CVD Any Transient Ischemic Attack, Cerebrovascular
Accident/Stroke, history of cerebrovascular
surgery, or any carotid disease.
PVD Whether the patient has Peripheral Vascular
Disease, as indicated by claudication;
amputation for arterial insufficiency; aorto-iliac
occlusive disease reconstruction; peripheral
vascular bypass surgery, angioplasty, or stent;
documented AAA.
Frailty Any deficiency in the Katz index of Activities of
Daily Living (independence in feeding, bathing,
dressing, transferring, toileting, and urinary
continence), as well as independence in
ambulation (no walking aid or assist required)
or any clear evidence of a previous diagnosis of
dementia by a physician.
EF<40 Ejection fraction measured less than 40% by any
modality.
NYHA (I-IV) New York Heart Association Class. I = Patients
with cardiac disease but without limitation of
physical activity. II = Patients with cardiac disease
resulting in slight limitation of physical activity
(fatigue, palpitations, dyspnea, or anginal pain).
III = Patients with cardiac disease resulting in
marked limitation of physical activity. IV = Patients
with cardiac disease resulting in inability to carry
on any physical activity without discomfort.
Symptoms of cardiac insufficiency or of the
anginal syndrome may be present even at rest.
Hemoglobin Most recent hemoglobin level prior to day of
surgery.
Pre-op creatinine Highest preop serum creatinine for this
admission.
Redo sternotomy Any history of previous surgery that traversed
the anterior mediastinum.
Surigical priority Elective [stable at home], in-house [requiring
hospitalization until the time of surgery], urgent
[requiring surgery within 24 hours to minimize
further clinical deterioration], or emergent [no
delay in surgery].
Procedure Any Coronary artery bypass grafting, aortic valve
replacement or repair with/without CABG, or Mitral
valve replacement or repair with/without CABG.
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as well as calibration plots [24]. Deciles of observed
and predicted probabilities of MACE were plotted for
the calibration plots [5]. Bootstrap procedure was used
to internally validate the model.All statistical analysis was performed using SAS soft-
ware version 9.2 (SAS, Cary, NC).
Approval for conducting this study was obtained from
the Institutional Review Board of the Capital District
Health Authority. The requirement to obtain informed
consent was waived under Section 2.1c of the Tri-Council
Policy Statement. All personal identifiers were stripped
prior to data analysis to ensure patient anonymity and
confidentiality.
The authors had full access to the data and take full
responsibility for its integrity. All authors have read and
agree to the manuscript as written.
Results
Population
A total of 4,270 patients underwent CABG, valve (aortic
valve replacement, mitral valve replacement, or mitral
valve repair) or CABG + valve at the QEII HSC from Jan
2004 to Dec 2009. The model cohort was 65% of the
total case volume (6,525) performed during the study
period. The distributions of risk factors in the develop-
ment cohort are displayed in Table 2. The prevalence of
MACE in this cohort was 15.7% (n=669). The prevalence
of MACE was higher in the CABG plus valve group
(32%, n=155) than in the isolated procedures (CABG
13%, n=416; Valve 14%, n=98). The frequencies of
MACE for each procedure as well as the components of
MACE are summarized in Table 3.
Model development
Assessment of the variance inflation for each variable
revealed that no variable exceeded 4.0 allowing all vari-
ables to remain in the final model (see Additional file 1:
Table 5).
By LOESS regression, the squared transformation of the
continuous variable age had the most linear relationship
with the logodds of the outcome (see Additonal file 1:
Figure 2-3). Hemoglobin and creatinine had non-linear re-
lationships with the outcome despite transformations. The
inflection points of the natural variable were taken to
create categorical variables. Hemoglobin inflection points
were 115 and 135 and creatinine was 115, 140, and 160.
A total of 16 variables remain in the logistic regression
model (Table 4). Significant predictors of MACE include
variables such as Frailty, BMI >35, all levels of Creatin-
ine, DM, Emergent and Urgent status and CABG + valve
procedure type. Model beta coefficients are presented in
the Additional file 1: Table 5.
Model performance
The concordance statistic for the logistic regression was
0.764, which is equivalent to an ROC of 76.4% (95% CI;
75–79). The Hosmer-Lemeshow goodness of fit statistic
was not significant (p=0.3133).
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Female 25 21 39 31
BMI
(kg/m2)
<25 22 20 28 26
25-30 40 40 41 43
30-35 25 27 18 23
>35 13 13 13 8
Diabetes 36 40 23 34
Pre-op Afib 12 9 21 22
COPD 15 14 18 17
CVD 14 14 13 17
PVD 17 19 7 18
Frailty 4 3 6 8
EF<40 15 15 11 20
NYHA I 35 44 13 13
II 23 23 29 21
III 26 20 42 42
IV 15 13 17 24
HGB (g/L) <115 50 52 49 38
115-135 33 32 32 41
>135 17 15 19 21
Pre-op
creatinine
<115 74 76 78 62
(μmol/L) 115-140 14 13 12 18
140-160 5 5 3 8
>160 7 7 7 11
Redo
sternotomy
7 4 19 11
Status Elective 47 44 59 44
In-house 41 41 36 43
Urgent 9 11 4 10
Emergent 3 4 2 3
BMI Body mass index, HGB Hemoglobin, Afib Atrial Fibrillation, COPD Chronic
Obstructive Pulmonary Disease, CVD Cerebro Vascular Disease, PVD Peripheral
Vascular Disease, EF Ejection Fraction, NYHA New York Heart Association.
Table 3 Frequency of MACE and MACE components in







n=4270 n=3095 n=696 n=479
(%) (%) (%) (%)
MACE* 15.7 13.0 14.0 32.0
Mortality 4.2 3.3 3.3 11.5
Acute renal
failure
6.5 5.5 5.5 14.0
Any stroke 2.9 2.3 2.4 7.3
Transient
(<24 h)
1.7 0.9 1.2 3.1
Permanent 1.7 1.4 1.3 4.2
Infection 8.0 7.1 6.3 16.1
Deep sternal
Wound infection
1.1 1.0 0.1 2.9
Sepsis 2.8 2.4 1.9 7.3
Pneumonia 6.5 5.7 5.3 13.6
*MACE—Major Adverse Cardiac Event defined as in-hospital death, stroke
(persisting at discharge or transient), acute renal failure (new post-operative
renal failure or acute on chronic (>50% increase from baseline creatinine)), or
infection (sepsis, pneumonia, or deep sternal wound infection).
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MACE are plotted (Figure 1). Each data points falls on or
very near the ideal line indicating excellent calibration.
Discussion
This paper outlines the development of a logistic regres-
sion model. Our model is unique for three reasons: 1) it
performs well in a heterogeneous population including
CABG, valve, and CABG + valve patients, 2) it predicts acomposite outcome of quality indicators including death
and major morbidities and, 3) it was developed for a con-
temporary cohort that represents a contemporary cardiac
surgery practice. Also, we could not identify in the litera-
ture any models that include a CABG, valve and valve +
CABG population with a composite end point.
Although many models exist that describe isolated
CABG or isolated valve [1-9,16-18], their use is limited
to only a percentage of the cardiac surgical population.
EuroSCORE, perhaps the most widely recognized car-
diac surgical predictive model, is a mixed population
model that has had great success in research and as a
quality improvement tool [11,18]. However, its deri-
vation cohort is over 15 years old restricting its applic-
ability to a contemporary practice. Our model is derived
from a 2004–2009 cohort allowing for more current
application. The EuroSCORE II has failed to perform
better then the original model in certain procedure type
subsets [13,14]. Furthermore both EuroSCORE models
only predicts mortality, and not other important quality
indicators.
Provided the model performs well, the advantage of a
heterogeneous population model exceeds that of single-
procedure models in its ability to describe to majority of
surgical patients and can help facilitate quality improve-
ment efforts. However, certain predictive variables, such
as descriptions of coronary artery disease or valve disease
severity, cannot be included in the model, as they do not
apply to the entire model derivation cohort. This might be
problematic, as some variables like left main disease have
Table 4 Logistic regression for MACE in a CABG/Valve
population
Variable Odds ratio 95% confidence
limit








NYHA I 1.0 -
NYHA II 1.2 0.9-1.6
NYHA III 1.2 0.9-1.5
NYHA IV 1.3 1.0-1.8
HGB <115 1.2 1.0-1.5
HGB 115-135 1.8 1.3-2.3
HGB >135 1.0 -




Preop Afib 1.4 1.1-1.8
Diabetes 1.5 1.1-1.8




Preop RF 1.3 0.9-1.9
Procedure CABG 1.0 -
Valve 1.2 0.9-1.5
CABG + Valve 2.3 1.8-3.0





Figure 1 Calibration plot of observed risk versus predicted risk.
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portant variables to include in CABG mortality models
[25]. Although our model cannot contain this variable (as
it would be entirely co-linear with CABG patients), it does
contain other clinically relevant variables previously used
in other published models [1-9,16-18].
Modeling composite outcomes allows for a broader pre-
diction of important post-operative events rather than
being limited to a single outcome. Also, the components
of our composite are each identified as quality indicatorsin cardiac surgery [15] allowing for improved clinical
validity. The benefit of a correctly chosen composite out-
come allows for more detailed description and prediction
of the clinical population increasing the clinical relevance
of the model.
The model discrimination is high with a ROC 76.4%
(75–79, 95% CI) that exceeds published recommenda-
tions [26] and is similar to other published cardiac surgi-
cal models [1-9,16-18]. This indicates that the model has
good predictive ability. The bootstrap procedure, a form
of internal validation [27,28], allows for estimation of the
95% confidence interval. The tight 95% confidence inter-
val provides a further estimation of reliability of the
model. The calibration plot allows for a visual represen-
tation of the model’s performance (Figure 1). The ob-
served to expected (O/E) data points fall on or very near
the ideal line indicating excellent calibration of the
model. The model performed well for each individual
procedure subset as well (isolated CABG, isolated valve,
CABG/valve).
Conclusions
We provide a statistically and clinically relevant model
that is an essential tool in the era of quality improve-
ment. The model includes heterogeneous procedures
and a composite outcomes increasing its utility.
As the profile of the cardiac surgery patients changes, so
must the predictive models used to describe this group.
This is of utmost importance in the field of quality assess-
ment and improvement. Models such as the one reported
in this manuscript, assists many QI techniques. They can
be used to perform pre-operative predictive risk matching
to allow for comparison of matched groups and can risk
adjust surgeon specific surgical outcomes for report
carding [24,26,29]. The benefit of the mixed population
and composite end points facilitates describing a contem-
porary clinical practice so that QI efforts are more pro-
ductive. Developers of such models must be dedicated to
upholding high statistical standards, so that the QI efforts
Herman et al. Journal of Cardiothoracic Surgery 2013, 8:177 Page 6 of 6
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in cardiac surgery practice, models such as these are es-
sential in propelling advancement in this field and improv-
ing outcomes for our patients.
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